CSIMarket
 


Agios Pharmaceuticals Inc   (AGIO)
Other Ticker:  
 
 

AGIO's Operating Income Growth by Quarter and Year

Agios Pharmaceuticals Inc 's Operating Income results by quarter and year




AGIO Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -106.28 -99.17 -104.83 -92.43
III Quarter September -100.90 -91.09 -91.15 -90.33
II Quarter June -93.70 -97.64 -91.22 -90.20
I Quarter March -90.61 -101.15 -91.22 -43.19
FY   -391.49 -389.05 -378.42 -316.15



AGIO Operating Income fourth quarter 2023 Y/Y Growth Comment
Agios Pharmaceuticals Inc in the fourth quarter 2023 recorded Operating Loss of $ -106.28 millions.

According to the results reported in the fourth quarter 2023, Agios Pharmaceuticals Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Agios Pharmaceuticals Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


AGIO Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Agios Pharmaceuticals Inc 's fourth quarter 2023 Operating Income $ -106.28 millions AGIO's Income Statement
Agios Pharmaceuticals Inc 's fourth quarter 2022 Operating Income $ -99.17 millions Quarterly AGIO's Income Statement
New: More AGIO's historic Operating Income Growth >>


AGIO Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Agios Pharmaceuticals Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AGIO's IV. Quarter Q/Q Operating Income Comment
IV. Quarter 2023 Operating Loss of -106.28 millions by Agios Pharmaceuticals Inc come out even more unfavourable compare to the Operating Loss -100.90 millions a quarter before.

Within Major Pharmaceutical Preparations industry Agios Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Agios Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AGIO's IV. Quarter Q/Q Operating Income Comment
IV. Quarter 2023 results of -106.28 millions by Agios Pharmaceuticals Inc look even more unfavourable compare to the Operating Loss -100.90 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Agios Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Agios Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Agios Pharmaceuticals Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -391.49 $ -384.38 $ -374.58 $ -378.52 $ -389.05
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Agios Pharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -391 millions in the Dec 31 2023 period.
The business is worsening as the cumulative Operating Loss is getting bigger from $ -384.38 millions in TTM ending quarter Sep 30 2023 and $ -394.702 millions for the twelve months ending in the quarter Dec 31 2022.

Agios Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Agios Pharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -391 millions in the Dec 31 2023 period.
The situation is detiriorating as the cumulative Operating Loss is becoming larger from $ -384.38 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -394.702 millions from the TTM period ending Dec 31 2022.

Agios Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AGIO's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AGIO's Competitors
Operating Income Growth for Agios Pharmaceuticals Inc 's Suppliers
Operating Income Growth for AGIO's Customers

You may also want to know
AGIO's Annual Growth Rates AGIO's Profitability Ratios AGIO's Asset Turnover Ratio AGIO's Dividend Growth
AGIO's Roe AGIO's Valuation Ratios AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio
AGIO's Roa AGIO's Inventory Turnover Ratio AGIO's Growth Rates AGIO's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Alpha Tau Medical Ltd 11.03%$ 11.028 millions
Sonida Senior Living Inc 11.02%$ 11.019 millions
Merit Medical Systems Inc10.50%$ 10.504 millions
Idexx Laboratories Inc8.29%$ 8.288 millions
Surgery Partners Inc 7.64%$ 7.643 millions
Haemonetics Corporation6.24%$ 6.236 millions
Novartis Ag6.22%$ 6.219 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com